| 000 | 01811 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515205439.0 | ||
| 264 | 0 | _c20100324 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0300-0605 | ||
| 024 | 7 |
_a10.1177/147323000903700628 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKonya, H | |
| 245 | 0 | 0 |
_aPleiotropic effects of mitiglinide in type 2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bThe Journal of international medical research _c |
||
| 300 |
_a1904-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAlbuminuria _xcomplications |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aDeoxyglucose _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aFasting _xblood |
| 650 | 0 | 4 |
_aFatty Acids _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aIsoindoles _xpharmacology |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostprandial Period _xdrug effects |
| 650 | 0 | 4 | _aRegression Analysis |
| 700 | 1 | _aMiuchi, M | |
| 700 | 1 | _aKonishi, K | |
| 700 | 1 | _aNagai, E | |
| 700 | 1 | _aUeyama, T | |
| 700 | 1 | _aKusunoki, Y | |
| 700 | 1 | _aKimura, Y | |
| 700 | 1 | _aNakamura, Y | |
| 700 | 1 | _aIshikawa, T | |
| 700 | 1 | _aInokuchi, C | |
| 700 | 1 | _aKatsuno, T | |
| 700 | 1 | _aHamaguchi, T | |
| 700 | 1 | _aMiyagawa, J | |
| 700 | 1 | _aNamba, M | |
| 773 | 0 |
_tThe Journal of international medical research _gvol. 37 _gno. 6 _gp. 1904-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/147323000903700628 _zAvailable from publisher's website |
| 999 |
_c19517643 _d19517643 |
||